Skip to main content
SpringerLink
Log in

Therapeutic Endoscopy in the Management of Pancreatic Cancer

  • Reference work entry
  • First Online:
Pancreatic Cancer

  • 1973 Accesses

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) is a safe and reliable method for the diagnosis, treatment, and palliation of pancreaticobiliary malignancy. In 2015, the estimated new cases of pancreatic cancer were about 48,960. The 5-year survival of pancreatic cancer is dismal at approximately 5% Siegel et al. (CA: Cancer J Clin 65(1):5–29, 2015). ERCP provides less invasive approaches to diagnosis with examination of the biliary and pancreatic ducts. The procedure also allows for therapeutic relief of biliary obstruction. Advanced endoscopic techniques offer palliation of symptoms related to advanced pancreatic cancer and improvement in quality of life. This chapter addresses the use of therapeutic endoscopy in the diagnosis and management of pancreatic adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 849.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Eloubeidi MA, et al. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointest Endosc. 2016;83(1):17–28.

    Article  Google Scholar 

  2. Kalady MF, et al. Pancreatic duct strictures: identifying risk of malignancy. Ann Surg Oncol. 2004;11(6):581–8.

    Article  Google Scholar 

  3. Hartmann D, et al. ERCP and MRCP in the differentiation of pancreatic tumors. Dig Dis. 2004;22(1):18–25.

    Article  Google Scholar 

  4. Andersson R, Vagianos CE, Williamson RCN. Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma. HPB. 2004;6(1):5–12.

    Article  CAS  Google Scholar 

  5. Shah SA, Movson J, Ransil BJ, Waxman I. Pancreatic duct stricture length at ERCP predicts tumor size and pathological stage of pancreatic cancer. Am J Gastroenterol. 1997;92(6):964–7.

    CAS  PubMed  Google Scholar 

  6. Asbun HJ, et al. When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery. 2014;155(5):887–92.

    Article  Google Scholar 

  7. Kim YS, et al. The significance of p53 and K-ras immunocytochemical staining in the diagnosis of malignant biliary obstruction by Brush Cytology during ERCP. Gut Liver. 2010;4(2):219–25.

    Article  Google Scholar 

  8. Wight CO, et al. Improving diagnostic yield of biliary brushings cytology for pancreatic cancer and cholangiocarcinoma. Cytopathology. 2004;15(2):87–92.

    Article  CAS  Google Scholar 

  9. Kipp BR, et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol. 2004;99(9):1675–81.

    Article  Google Scholar 

  10. Gonda TA, et al. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures. Gastrointest Endosc. 2012;75(1):74–9.

    Article  Google Scholar 

  11. Naitoh I, et al. Predictive factors for positive diagnosis of malignant biliary strictures by transpapillary brush cytology and forceps biopsy. J Dig Dis. 2016;17(1):44–51.

    Article  Google Scholar 

  12. Navaneethan U, et al. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015;81(1):168–76.

    Article  Google Scholar 

  13. Yang J, et al. K-ras mutational status in cytohistological tissue as a molecular marker for the diagnosis of pancreatic cancer: a systematic review and meta-analysis. Dis Markers. 2014;2014:573783.

    PubMed  PubMed Central  Google Scholar 

  14. Mikata R, et al. Clinical usefulness of repeated pancreatic juice cytology via endoscopic naso-pancreatic drainage tube in patients with pancreatic cancer. J Gastroenterol. 2013;48(7):866–73.

    Article  Google Scholar 

  15. Tada M, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology. 1996;110(1):227–31.

    Article  CAS  Google Scholar 

  16. Gress TM. Molecular diagnosis of pancreatobiliary malignancies in brush cytologies of biliary strictures. Gut. 2004;53(12):1727–9.

    Article  CAS  Google Scholar 

  17. Fukuda Y, et al. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc. 2005;62(3):374–82.

    Article  Google Scholar 

  18. Chen YK, et al. Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc. 2011;74(4):805–14.

    Article  Google Scholar 

  19. Parsi MA, et al. Diagnostic and therapeutic cholangiopancreatoscopy: performance of a new digital cholangioscope. Gastrointest Endosc. 2014;79(6):936–42.

    Article  Google Scholar 

  20. Kurihara T, et al. Diagnostic and therapeutic single-operator cholangiopancreatoscopy in biliopancreatic diseases: prospective multicenter study in Japan. World J Gastroenterol. 2016;22(5):1891–901.

    Article  CAS  Google Scholar 

  21. Smith AC, et al. Randomised trial of endoscopic steriting versus surgical bypass in malignant low bile duct obstruction. Lancet. 1994;344(8938):1655–60.

    Article  CAS  Google Scholar 

  22. Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc. 2002;56(6):835–41.

    Article  Google Scholar 

  23. Ballinger AB, et al. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut. 1994;35(4):467–70.

    Article  CAS  Google Scholar 

  24. Pfau PR, et al. Pancreatic and biliary stents. Gastrointest Endosc. 2013;77(3):319–27.

    Article  Google Scholar 

  25. Boulay BR, Parepally M. Managing malignant biliary obstruction in pancreas cancer: choosing the appropriate strategy. World J Gastroenterol. 2014;20(28):9345–53.

    PubMed  PubMed Central  Google Scholar 

  26. Kullman E, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72(5):915–23.

    Article  Google Scholar 

  27. Isayama H, et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol. 2006;4(9):1148–53.

    Article  Google Scholar 

  28. Maire F, et al. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol. 2006;101(4):735–42.

    Article  Google Scholar 

  29. Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc. 2006;63(7):986–95.

    Article  Google Scholar 

  30. Cavell LK, et al. Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy. Am J Gastroenterol. 2013;108(7):1168–73.

    Article  Google Scholar 

  31. Sasahira N, et al. Multicenter study of endoscopic preoperative biliary drainage for malignant distal biliary obstruction. World J Gastroenterol. 2016;22(14):3793–802.

    Article  CAS  Google Scholar 

  32. Fang Y, et al. Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev. 2012;9:CD005444.

    PubMed Central  Google Scholar 

  33. Gavazzi F, et al. Role of preoperative biliary stents, bile contamination and antibiotic prophylaxis in surgical site infections after pancreaticoduodenectomy. BMC Gastroenterol. 2016;16:43.

    Article  Google Scholar 

  34. Aadam AA, et al. Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. Gastrointest Endosc. 2012;76(1):67–75.

    Article  Google Scholar 

  35. Fathi A, et al. Neoadjuvant therapy for localized pancreatic cancer: guiding principles. J Gastrointest Oncol. 2015;6(4):418–29.

    PubMed  PubMed Central  Google Scholar 

  36. Sanders MK, et al. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc. 2010;71(7):1178–84.

    Article  Google Scholar 

  37. Chavalitdhamrong D, et al. Technical advances in endoscopic ultrasound-guided fiducial placement for the treatment of pancreatic cancer. Endosc Int Open. 2015;3(4):E373–7.

    Article  Google Scholar 

  38. Stark A, Hines OJ. Endoscopic and operative palliation strategies for pancreatic ductal adenocarcinoma. Semin Oncol. 2015;42(1):163–76.

    Article  Google Scholar 

  39. Maetani I. Self-expandable metallic stent placement for palliation in gastric outlet obstruction. Ann Palliat Med. 2014;3(2):54–64.

    PubMed  Google Scholar 

  40. Sasaki R, et al. Endoscopic management of unresectable malignant gastroduodenal obstruction with a nitinol uncovered metal stent: a prospective Japanese multicenter study. World J Gastroenterol. 2016;22(14):3837–44.

    Article  CAS  Google Scholar 

  41. Mehta S, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc Int Tech. 2006;20(2):239–42.

    Article  CAS  Google Scholar 

  42. Puli SR, et al. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci. 2009;54(11):2330–7.

    Article  Google Scholar 

  43. Alvarez-Sánchez MV, et al. Interventional endoscopic ultrasonography: an overview of safety and complications. Surg Endosc. 2014;28(3):712–34.

    Article  Google Scholar 

  44. Costamagna G, et al. Treatment of “obstructive” pain by endoscopic drainage in patients with pancreatic head carcinoma. Gastrointest Endosc. 1993;39(6):774–7.

    Article  CAS  Google Scholar 

  45. Wehrmann T, et al. Endoscopic pancreatic duct stenting for relief of pancreatic cancer pain. Eur J Gastroenterol Hepatol. 2005;17(12):1395–400.

    Article  Google Scholar 

  46. Sanders M, et al. Endoscopic palliation of pancreatic cancer. Gastroenterol Clin North Am. 2007;36(2):455–76.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA

    Alyson McGhan & Rebecca Burbridge

Authors
  1. Alyson McGhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebecca Burbridge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rebecca Burbridge .

Editor information

Editors and Affiliations

  1. Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany

    John P. Neoptolemos

  2. Division of Research Department of Surgery and Genomic Sciences and Precision Medicine Center (GSPMC), Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Raul Urrutia

  3. Division of Medical Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA

    James L. Abbruzzese

  4. Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany

    Markus W. Büchler

Section Editor information

  1. Duke University Medical Center, Durham, NC, USA

    James L. Abbruzzese

  2. Mayo Clinic Cancer Center, Mayo Clinic, 200 First Street SW, 55905, Rochester, MN, USA

    Raul A. Urrutia

  3. Division of Surgery and Oncology, University of Liverpool, Daulby Street, Liverpool, UK

    John Neoptolemos

  4. Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany

    Markus W. Büchler

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

McGhan, A., Burbridge, R. (2018). Therapeutic Endoscopy in the Management of Pancreatic Cancer. In: Neoptolemos, J., Urrutia, R., Abbruzzese, J., Büchler, M. (eds) Pancreatic Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7193-0_87

Download citation

Publish with us

Policies and ethics

Search

Navigation